Precision psychiatry aims to move beyond traditional symptom-based diagnostic frameworks which group biologically heterogeneous patients under the same diagnosis. By integrating contextual information, genetic data, blood biomarkers, symptom profiles and neuroimaging findings, patients can be stratified into mechanism-based subtypes. This stratification enables the identification of targeted therapeutic strategies matched to the underlying biological mechanisms. This can improve treatment efficacy and reduce the current trial-and-error approach.
Related content
Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials.
Sequential treatment optimization scheme for major depressive disorder generated according to international evidence.
Key steps for managing factors that may confound antidepressant treatment response, including dose, side effects, comorbidities, stressors, adherence, pharmacogenomics, interactions, and treatment algorithms.